Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neurofibroma, Plexiform 3Neurofibromatosis 1 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Radiation Fibrosis Syndrome 1Precancerous Conditions 1Pneumonia 1Neurofibromatoses 1Nerve Sheath Neoplasms 1Neoplasms 1Myofibroma 1Lymphedema 1Leiomyoma 1Colorectal Neoplasms 1Acute Lung Injury 1

Interventions

Misoprostol 6Uterine Myomectomy 4relugolix 3Tranexamic Acid 3Saline Solution 3Hysterectomy 3dienogest 2carbetocin 2Uterine Artery Embolization 2Tourniquets 2Tablets 2Lidocaine 2Leuprolide 2Hysteroscopy 2Ascorbic Acid 2ulipristal 1telapristone acetate 1remimazolam 1ramosetron 1pirfenidone 1estradiol, norethindrone drug combination 1Vasopressins 1Triptorelin Pamoate 1Tranylcypromine 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myofibroma × pirfenidone × Clear all
NCT00332033 2017-07-02

Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
32 enrolled

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡